www.newsmax.com
Biogen Discontinues Alzheimer's Drug Aduhelm
Biogen Inc said on Wednesday it will discontinue the development and commercialization of its controversial first Alzheimer's drug‚ Aduhelm‚ to focus on the second medicine Leqembi and develop newer treatments for the mind-wasting disease....